Found: 5000
Select item for more details and to access through your institution.
Oral lichenoid drug eruption due to osimertinib for lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1278, doi. 10.1177/10781552241268693
- By:
- Publication type:
- Article
Inhibitory effect of 1,4,5,6-tetrahydroxy-7,8-diprenylxanthone against NSCLC with L858R/T790M/C797S mutant EGFR.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-78146-3
- By:
- Publication type:
- Article
Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4643, doi. 10.1007/s00277-024-06027-w
- By:
- Publication type:
- Article
15-year remission in refractory FLT3-mutated AML attained by sorafenib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4801, doi. 10.1007/s00277-024-06012-3
- By:
- Publication type:
- Article
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4811, doi. 10.1007/s00277-024-06011-4
- By:
- Publication type:
- Article
Recent advances in CD5<sup>+</sup> diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4401, doi. 10.1007/s00277-024-05974-8
- By:
- Publication type:
- Article
Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4765, doi. 10.1007/s00277-024-05924-4
- By:
- Publication type:
- Article
Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4649, doi. 10.1007/s00277-024-05797-7
- By:
- Publication type:
- Article
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4537, doi. 10.1007/s00277-024-05906-6
- By:
- Publication type:
- Article
The benefit and risk of addition of chemotherapy to EGFR tyrosine kinase inhibitors for EGFR-positive non-small cell lung cancer patients with brain metastases: a meta-analysis based on randomized controlled trials.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1448336
- By:
- Publication type:
- Article
A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1382856
- By:
- Publication type:
- Article
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1068, doi. 10.4143/crt.2024.008
- By:
- Publication type:
- Article
Efficacy of Lenvatinib Combined with Anti–PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1207, doi. 10.4143/crt.2023.1165
- By:
- Publication type:
- Article
Targeting Breast Cancer with Dasatinib Derivatives: A Multi-Parameter Strategy to Uncover Potent Lead Compounds.
- Published in:
- International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 4, p. 1260, doi. 10.5530/ijpi.14.4.139
- By:
- Publication type:
- Article
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 6, p. 1, doi. 10.1016/j.aohep.2024.101534
- By:
- Publication type:
- Article
In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells.
- Published in:
- Applied Biological Chemistry, 2024, v. 67, n. 1, p. 1, doi. 10.1186/s13765-024-00952-0
- By:
- Publication type:
- Article
PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status.
- Published in:
- Advanced Pharmaceutical Bulletin, 2024, v. 14, n. 3, p. 665, doi. 10.34172/apb.2024.058
- By:
- Publication type:
- Article
Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 21, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2791
- By:
- Publication type:
- Article
Successful Management of Incompletely Resected Transitional Cell Carcinoma with Sorafenib Tosylate in a Dog.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Primary Pulmonary Leiomyosarcoma Managed With Pazopanib: A Case Report and Literature Review.
- Published in:
- Therapeutic Advances in Pulmonary & Critical Care Medicine, 2024, p. 1, doi. 10.1177/29768675241279709
- By:
- Publication type:
- Article
Deucravacitinib: moderate-to-severe plaque psoriasis preventable?
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2024, v. 35, n. 4/5, p. 225, doi. 10.1515/jbcpp-2023-0174
- By:
- Publication type:
- Article
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case Series Study and Literature Review.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 10, p. 465, doi. 10.1159/000540662
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 10, p. 1477, doi. 10.1007/s40262-024-01412-0
- By:
- Publication type:
- Article
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02220-y
- By:
- Publication type:
- Article
Radiotherapy plus lenvatinib versus radiotherapy plus sorafenib for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1458819
- By:
- Publication type:
- Article
New ABL1 Kinase Domain Mutations in BCR::ABL1‐Positive Acute Lymphoblastic Leukemia.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 20, p. 1, doi. 10.1002/cam4.70317
- By:
- Publication type:
- Article
Systemic treatments for radioiodine-refractory thyroid cancers.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2024.1346476
- By:
- Publication type:
- Article
ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3501, doi. 10.3390/cancers16203501
- By:
- Publication type:
- Article
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3458, doi. 10.3390/cancers16203458
- By:
- Publication type:
- Article
Chronic Phase Chronic Myeloid Leukemia: More Drugs, More Lives Saved, New Challenges.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Optimal First-Line Treatment of Chronic Myeloid Leukemia: How to Use Imatinib and What Role for Newer Drugs?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 6, p. 653
- By:
- Publication type:
- Article
The Unfolding Story of Imatinib Mesylate for Chronic Myeloid Leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
New Therapeutics for Soft-Tissue Sarcomas in Adults.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 123
- By:
- Publication type:
- Article
Anti-EGFR Therapies: Clinical Experience in Colorectal, Lung, and Head and Neck Cancers.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 15
- By:
- Publication type:
- Article
EGFR Inhibitors in Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 13, p. 1707
- By:
- Publication type:
- Article
Current Strategies in the Management of Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 13, p. 1667
- By:
- Publication type:
- Article
Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2012, v. 69, n. 1, p. 37, doi. 10.2298/VSP1201037S
- By:
- Publication type:
- Article
Faktori koji utiču na postizanje i postojanost citogenetskog odgovora kod bolesnika sa hroničnom mijeloidnom leukemijom na terapiji imatinibom.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2011, v. 68, n. 11, p. 911, doi. 10.2298/VSP1111911C
- By:
- Publication type:
- Article
Mastocytosis: Classification, Diagnosis, and Clinical Presentation.
- Published in:
- Allergy & Asthma Proceedings, 2004, v. 25, n. 1, p. 33
- By:
- Publication type:
- Article
Myocarditis Following Pembrolizumab Plus Axitinib, and Belzutifan Plus Lenvatinib for Renal Cell Carcinoma: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Mitochondrial Dysfunction in Cardiotoxicity Induced by BCR-ABL1 Tyrosine Kinase Inhibitors -Underlying Mechanisms, Detection, Potential Therapies.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 7/8, p. 233, doi. 10.1007/s12012-023-09800-x
- By:
- Publication type:
- Article
Cardiac Remodelling Following Cancer Therapy: A Review.
- Published in:
- Cardiovascular Toxicology, 2022, v. 22, n. 9, p. 771, doi. 10.1007/s12012-022-09762-6
- By:
- Publication type:
- Article
The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with Specificity.
- Published in:
- Cardiovascular Toxicology, 2017, v. 17, n. 3, p. 297, doi. 10.1007/s12012-016-9386-7
- By:
- Publication type:
- Article
Determinants of Atrial Fibrillation Development among Patients undergoing Ibrutinib Therapy.
- Published in:
- Clinical Medicine & Research, 2022, v. 20, n. 1, p. 16, doi. 10.3121/cmr.2021.1693
- By:
- Publication type:
- Article
Investigation of the EGFR gene variations in bladder cancer patients using INFINITI Analyzer.
- Published in:
- Journal of Cell & Molecular Biology, 2011, v. 9, n. 1, p. 83
- By:
- Publication type:
- Article
Biology - Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 2, p. 58
- Publication type:
- Article
Treatment -- Metastatic and Advanced Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2008, v. 20, n. 4, p. 124
- Publication type:
- Article
Simultaneous determination of nine tyrosine kinase inhibitors in three complex biological matrices by using high‐performance liquid chromatography–diode array detection combined with a second‐order calibration method.
- Published in:
- Journal of Separation Science, 2021, v. 44, n. 21, p. 3914, doi. 10.1002/jssc.202100293
- By:
- Publication type:
- Article
Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 37, p. 20358, doi. 10.1002/ange.202105351
- By:
- Publication type:
- Article
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 148, doi. 10.1111/bjh.15397
- By:
- Publication type:
- Article